Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

661 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?
Rook GA, Dheda K, Zumla A. Rook GA, et al. Among authors: zumla a. Vaccine. 2005 Mar 18;23(17-18):2115-20. doi: 10.1016/j.vaccine.2005.01.069. Vaccine. 2005. PMID: 15755581 Review.
Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile?
Rook GA, Zumla A. Rook GA, et al. Among authors: zumla a. Lancet. 1997 Jun 21;349(9068):1831-3. doi: 10.1016/S0140-6736(97)01164-1. Lancet. 1997. PMID: 9269228
Paradox of the global emergency of tuberculosis.
Grange JM, Zumla A. Grange JM, et al. Among authors: zumla a. Lancet. 1999 Mar 20;353(9157):996. doi: 10.1016/S0140-6736(99)01196-4. Lancet. 1999. PMID: 10459922 No abstract available.
Historical declines in tuberculosis: nature, nurture and the biosocial model.
Grange JM, Gandy M, Farmer P, Zumla A. Grange JM, et al. Among authors: zumla a. Int J Tuberc Lung Dis. 2001 Mar;5(3):208-12. Int J Tuberc Lung Dis. 2001. PMID: 11326817
Infection and disease caused by environmental mycobacteria.
Zumla A, Grange J. Zumla A, et al. Curr Opin Pulm Med. 2002 May;8(3):166-72. doi: 10.1097/00063198-200205000-00003. Curr Opin Pulm Med. 2002. PMID: 11981303 Review.
Drugs for neglected diseases.
Zumla A. Zumla A. Lancet Infect Dis. 2002 Jul;2(7):393. doi: 10.1016/s1473-3099(02)00312-2. Lancet Infect Dis. 2002. PMID: 12127349 No abstract available.
Tuberculosis: amplification-based clinical diagnostic techniques.
Huggett JF, McHugh TD, Zumla A. Huggett JF, et al. Among authors: zumla a. Int J Biochem Cell Biol. 2003 Oct;35(10):1407-12. doi: 10.1016/s1357-2725(03)00102-x. Int J Biochem Cell Biol. 2003. PMID: 12818237 Review.
Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2.
Demissie A, Abebe M, Aseffa A, Rook G, Fletcher H, Zumla A, Weldingh K, Brock I, Andersen P, Doherty TM; VACSEL Study Group. Demissie A, et al. Among authors: zumla a. J Immunol. 2004 Jun 1;172(11):6938-43. doi: 10.4049/jimmunol.172.11.6938. J Immunol. 2004. PMID: 15153513
Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation.
Fletcher HA, Owiafe P, Jeffries D, Hill P, Rook GA, Zumla A, Doherty TM, Brookes RH; Vacsel Study Group. Fletcher HA, et al. Among authors: zumla a. Immunology. 2004 Aug;112(4):669-73. doi: 10.1111/j.1365-2567.2004.01922.x. Immunology. 2004. PMID: 15270739 Free PMC article.
In vivo and in vitro studies of a novel cytokine, interleukin 4delta2, in pulmonary tuberculosis.
Dheda K, Chang JS, Breen RA, Kim LU, Haddock JA, Huggett JF, Johnson MA, Rook GA, Zumla A. Dheda K, et al. Among authors: zumla a. Am J Respir Crit Care Med. 2005 Aug 15;172(4):501-8. doi: 10.1164/rccm.200502-278OC. Epub 2005 May 18. Am J Respir Crit Care Med. 2005. PMID: 15901609
661 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback